Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis

Lindsay Armstrong-Buisseret; Clare Brittain; Miruna David; Gillian Dean; Frances Griffiths; Trish Hepburn; Louise Jackson; Joe Kai; Alan Montgomery; Tracy Roberts; Sukhwinder Thandi; Jonathan D.C. Ross

doi:10.1186/s13063-019-3731-7

Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis

Lindsay Armstrong-Buisseret
, Clare Brittain
, Miruna David
, Gillian Dean
, Frances Griffiths
, Trish Hepburn
, Louise Jackson
, Joe Kai
, Alan Montgomery
, Tracy Roberts
, Sukhwinder Thandi
, Jonathan D.C. Ross^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

9 Citations (SciVal)

Original language	English
Article number	648
Journal	Trials
Volume	20
Issue number	1
DOIs	https://doi.org/10.1186/s13063-019-3731-7
Publication status	Published (VoR) - 27 Nov 2019

Keywords

Antibiotic usage
Bacterial vaginosis
Cost-benefit analysis
Lactic acid gel
Metronidazole
Recurrence
VITA

Access to Document

10.1186/s13063-019-3731-7

Fingerprint

Dive into the research topics of 'Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis'. Together they form a unique fingerprint.

Cite this

Armstrong-Buisseret, L., Brittain, C., David, M., Dean, G., Griffiths, F., Hepburn, T., Jackson, L., Kai, J., Montgomery, A., Roberts, T., Thandi, S., & Ross, J. D. C. (2019). Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis. Trials, 20(1), Article 648. https://doi.org/10.1186/s13063-019-3731-7

@article{dc26d27870664088baae8fc9655923d6,

title = "Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis",

keywords = "Antibiotic usage, Bacterial vaginosis, Cost-benefit analysis, Lactic acid gel, Metronidazole, Recurrence, VITA",

author = "Lindsay Armstrong-Buisseret and Clare Brittain and Miruna David and Gillian Dean and Frances Griffiths and Trish Hepburn and Louise Jackson and Joe Kai and Alan Montgomery and Tracy Roberts and Sukhwinder Thandi and Ross, \{Jonathan D.C.\}",

note = "Publisher Copyright: {\textcopyright} 2019 The Author(s).",

year = "2019",

month = nov,

day = "27",

doi = "10.1186/s13063-019-3731-7",

language = "English",

volume = "20",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

number = "1",

}

Armstrong-Buisseret, L, Brittain, C, David, M, Dean, G, Griffiths, F, Hepburn, T, Jackson, L, Kai, J, Montgomery, A, Roberts, T, Thandi, S & Ross, JDC 2019, 'Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis', Trials, vol. 20, no. 1, 648. https://doi.org/10.1186/s13063-019-3731-7

Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis. / Armstrong-Buisseret, Lindsay; Brittain, Clare; David, Miruna et al.
In: Trials, Vol. 20, No. 1, 648, 27.11.2019.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Metronidazole versus lactic acid for treating bacterial vaginosis (VITA)

T2 - protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis

AU - Armstrong-Buisseret, Lindsay

AU - Brittain, Clare

AU - David, Miruna

AU - Dean, Gillian

AU - Griffiths, Frances

AU - Hepburn, Trish

AU - Jackson, Louise

AU - Kai, Joe

AU - Montgomery, Alan

AU - Roberts, Tracy

AU - Thandi, Sukhwinder

AU - Ross, Jonathan D.C.

PY - 2019/11/27

Y1 - 2019/11/27

KW - Antibiotic usage

KW - Bacterial vaginosis

KW - Cost-benefit analysis

KW - Lactic acid gel

KW - Metronidazole

KW - Recurrence

KW - VITA

UR - https://www.scopus.com/pages/publications/85075745838

UR - https://www.scopus.com/pages/publications/85075745838#tab=citedBy

U2 - 10.1186/s13063-019-3731-7

DO - 10.1186/s13063-019-3731-7

M3 - Article

C2 - 31775859

AN - SCOPUS:85075745838

SN - 1745-6215

VL - 20

JO - Trials

JF - Trials

IS - 1

M1 - 648

ER -

Armstrong-Buisseret L, Brittain C, David M, Dean G, Griffiths F, Hepburn T et al. Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis. Trials. 2019 Nov 27;20(1):648. doi: 10.1186/s13063-019-3731-7

Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis

Keywords

Access to Document

Other files and links

Fingerprint

Cite this